Suppr超能文献

在上尿路尿路上皮癌行肾输尿管切除术后,输尿管和多灶性肿瘤比肾盂肿瘤的预后更差。

Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.

机构信息

Academic Department of Urology, CHU Lille, Univ Lille Nord de France, F-59000 Lille, France.

出版信息

Eur Urol. 2011 Dec;60(6):1258-65. doi: 10.1016/j.eururo.2011.05.049. Epub 2011 Jun 7.

Abstract

BACKGROUND

It is not known whether the primary tumour location of upper urinary tract urothelial carcinoma (UUT-UC) is associated with prognosis.

OBJECTIVE

To evaluate the impact of initial primary tumour location on survival in patients who had undergone radical nephroureterectomy (RNU).

DESIGN, SETTING, AND PARTICIPANTS: Using a multi-institutional, retrospective database, we identified 609 patients with UUT-UC who had undergone RNU between 1995 and 2010. Tumour location was categorised as renal pelvis, ureter, or multifocal.

INTERVENTION

All patients had undergone RNU.

MEASUREMENTS

Tumour location was tested as a prognostic factor for survival through univariate and multivariable Cox regression analysis.

RESULTS AND LIMITATIONS

Tumour location was renal pelvis in 317 cases (52%), ureter in 185 cases (30%), and multifocal in 107 cases (18%). Compared to renal pelvic and ureteral tumours, multifocal tumours were more likely to be associated with advanced stages (pT3/pT4; 39%, 30%, and 54%, respectively; p<0.001) and high-grade disease (53%, 56%, and 76%, respectively; p<0.001). On multivariable analysis, tumour location was an independent prognostic factor for cancer-specific death, disease recurrence, and metastasis (p<0.05). The 5-yr cancer-specific death-free survival probability was 86.8% for renal pelvic tumours, 68.9% for ureteral tumours, and 56.8% for multifocal tumours (p<0.001). The retrospective design of this study was its main limitation.

CONCLUSIONS

Ureteral and multifocal tumours had a worse prognosis than renal pelvic tumours. These findings are not in line with recently published data and should be investigated in a prospective assessment to obtain a definitive statement regarding this matter.

摘要

背景

上尿路上皮癌(UUT-UC)的原发肿瘤位置是否与预后相关尚不清楚。

目的

评估根治性肾输尿管切除术(RNU)后患者的初始原发肿瘤位置对生存的影响。

设计、设置和参与者:使用多机构回顾性数据库,我们确定了 1995 年至 2010 年间接受 RNU 的 609 例 UUT-UC 患者。肿瘤位置分为肾盂、输尿管或多灶性。

干预

所有患者均接受 RNU。

测量

通过单变量和多变量 Cox 回归分析,将肿瘤位置作为生存的预后因素进行检验。

结果和局限性

肿瘤位置为肾盂 317 例(52%),输尿管 185 例(30%),多灶性 107 例(18%)。与肾盂和输尿管肿瘤相比,多灶性肿瘤更有可能与晚期(pT3/pT4;分别为 39%、30%和 54%;p<0.001)和高级别疾病(分别为 53%、56%和 76%;p<0.001)相关。多变量分析显示,肿瘤位置是癌症特异性死亡、疾病复发和转移的独立预后因素(p<0.05)。肾盂肿瘤的 5 年癌症特异性无死亡生存概率为 86.8%,输尿管肿瘤为 68.9%,多灶性肿瘤为 56.8%(p<0.001)。本研究的主要局限性是回顾性设计。

结论

输尿管和多灶性肿瘤的预后比肾盂肿瘤差。这些发现与最近发表的数据不一致,应在前瞻性评估中进行研究,以对这一问题作出明确的陈述。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验